Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 15,335 | 13,753 | 15,381 | 14,758 | 15,485 |
| Operating Income | -15,335 | -13,753 | -15,381 | -14,758 | -15,485 |
| Other Income | 1,874 | 2,173 | 416 | 324 | 439 |
| Pre-tax Income | -13,461 | -11,580 | -14,965 | -14,434 | -15,046 |
| Net Income Continuous | -13,461 | -11,580 | -14,965 | -14,434 | -15,046 |
| Net Income | $-13,461 | $-11,580 | $-14,965 | $-14,434 | $-15,046 |
| EPS Basic Total Ops | -0.21 | -0.07 | -0.38 | -0.40 | -0.42 |
| EPS Basic Continuous Ops | -0.21 | -0.07 | -0.38 | -0.40 | -0.42 |
| EPS Diluted Total Ops | -0.21 | -0.07 | -0.38 | -0.40 | -0.42 |
| EPS Diluted Continuous Ops | -0.21 | -0.07 | -0.38 | -0.40 | -0.42 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.18 | -0.38 | -0.40 | -0.42 |
| EBITDA(a) | $-15,559 | $-13,736 | $-15,207 | $-14,581 | $-15,309 |